Dr Reddy's Laboratories announced the introduction of Toripalimab in India for treating recurrent or metastatic nasopharyngeal carcinoma. Nasopharyngeal carcinoma (NPC) is an uncommon, fast-growing type of head and neck cancer that starts in the...
The growth of the global manufacturing execution system in life sciences market is due to the rising need for real-time data and analytics and increasing regulatory compliance. The pharmaceutical sector is quickly embracing digital technology...
Dr. Veena Panicker, Director - BioMonitoring, Merck Life Science in a recent interaction with India Pharma Outlook shared her views on how the growing consumer demand for safer, higher-quality food and beverages in India has influenced the...
Alembic Pharmaceuticals has received final approval from the US FDA for its generic Diltiazem Hydrochloride extended-release capsules, which are indicated for the treatment of hypertension. The capsule's anticipated market size was USD 105.3...
Moderna, Inc., a pioneer in mRNA medicine development, revealed that Health Canada has authorized mRESVIA (mRNA vaccine for Respiratory Syncytial Virus) for active immunization aimed at preventing lower respiratory tract infections caused by...
While speaking at the 19th International Conference of Drug Regulatory Authorities, the Drug Controller General of India, Dr. Rajeev Singh Raghuvanshi, spoke at length on how India is playing a significant role in the global healthcare ecosystem...
Dr. Paromita Kanjilal Chakraborty is a Consultant in Emergency Medicine with over 8 years of experience. Holding an MBBS, DNB in Family Medicine, and MEM, she is skilled in acute care, trauma care, and emergency medical services. Dr. Chakraborty...
Akums Drugs & Pharmaceuticals Limited has joined forces with Apollo Hospitals to raise awareness during World Cancer Awareness Month. On October 5th, engaging awareness sessions were held at Akums' New Delhi Corporate Office and its subsidiary...
Approximately four billion individuals globally are in danger of arbovirus infections, with projections showing this number will rise to 5 billion by 2050. Dengue cases have increased in all six WHO regions, with the number of cases nearly...
Tagrisso (osimertinib) from AstraZeneca has been given the approval in the US to treat adult patients with unresectable, Stage III EGFRm NSCLC who have not seen their disease worsen after platinum-based CRT. Tagrisso is approved for individuals...
, CDSCO.jpg)
.jpg)